|
Delayed
NSE India S.E.
07:05:07 2026-08-25 EDT
|
5-day change | 1st Jan Change | ||
| 2,400.00 INR | +0.39% |
|
+4.12% | +17.92% |
| 08-03 | Glenmark Pharmaceuticals Limited, Q1 2027 Earnings Call, Aug 03, 2026 | |
| 07-31 | India's Glenmark Pharma posts higher quarterly profit on strong demand | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GLENMARK PHARMACEUTICALS LIMITED | Generic Pharmaceuticals | +0.39% | +4.12% | +17.92% | +22.69% | +361.80% | 7.05B |  |  | |
- Stock Market
- Stocks
- GLENMARK Stock
- Charts Glenmark Pharmaceuticals Limited
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
